SOW
TRDA icon

State of Wyoming’s Entrada Therapeutics TRDA Stock Holding History

State of Wyoming’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9K Buy
+5,014
New +$48.1K ﹤0.01% 1730
2025
Q3 		– Sell
-7,575
Closed -$50.9K – 2059
2025
Q2 		$50.9K Buy
7,575
+4,295
+131% +$34.6K 0.01% 1564
2025
Q1 		$29.7K Sell
3,280
-2,757
-46% -$34.4K ﹤0.01% 1551
2024
Q4 		$104K Buy
+6,037
New +$109K 0.01% 1164
2024
Q1 		– Sell
-5,932
Closed -$89.5K – 1825
2023
Q4 		$89.5K Buy
+5,932
New +$87.9K 0.02% 1064
2022
Q2 		– Sell
-1,060
Closed -$10K – 2139
2022
Q1 		$10K Buy
1,060
+829
+359% +$8.89K 0.01% 1608
2021
Q4 		$4K Buy
+231
New +$5.6K ﹤0.01% 1742

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

State of Wyoming's TRDA Position: Q2 2026 in Review

State of Wyoming opened a new position in Entrada Therapeutics (TRDA) in Q2 2026: 5,014 shares worth $36.9K. The stake represents ﹤0.01% of the portfolio and ranks #1730 among its holdings. This is a return to the name: State of Wyoming previously reported a position in TRDA as recently as Q2 2025.

State of Wyoming first reported a position in TRDA in Q4 2021 and has held it in 7 quarters since. The position peaked at $104K in Q4 2024. 128 funds tracked by Wall St. Rank hold TRDA as of Q2 2026.

  • State of Wyoming held 5,014 shares of Entrada Therapeutics worth $36.9K as of Q2 2026.
  • Entrada Therapeutics was a new State of Wyoming position in Q2 2026.
  • Entrada Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1730 holding.
  • State of Wyoming first reported a position in Entrada Therapeutics in Q4 2021 and has held it in 7 quarters since.
  • State of Wyoming's Entrada Therapeutics position peaked at $104K in Q4 2024.
  • 128 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.